EyeNet - American Academy of Ophthalmology

Ophthalmic Pearls

Retinitis Pigmentosa, Part 2: Research on Patient Management

By Xian Hui Lim, MBBS, Daniel S.W. Ting, MD, PhD, and Adrian Koh, MBBS, FRCS, MMED, FRCOphth, FAMS
Edited By: Ingrid U. Scott, MD, MPH, and Bennie Jeng, MD

Take a look at the research on treatments for RP in part 2 of the series on this blinding condition.

Comments 0
Views 976

Clinical Update

MD Roundtable: The Enduring Role of Traditional Glaucoma Surgery, Part 1

By Ruth D. Williams, MD, With Anne L. Coleman, MD, PhD, and Dale K. Heuer, MD

Three glaucoma experts discuss the role and importance of traditional glaucoma surgery in today’s MIGS-oriented environment.

Comments 0
Views 458

Vitreoretinal Surgery for COVID-19 Positive Patients

By Annie Stuart, Contributing Writer, interviewing Durga Borkar, MD, Gary N. Holland, MD, and Benjamin Reiss, MD

Surgeons who have operated on COVID-19 patients share their experiences and protocols.

Comments 0
Views 3366

Blink

Can You Guess July's Mystery Condition?

Make your diagnosis in the comments, and get the answer to last month’s mystery.

Comments 0
Views 3434

Journal Highlights

Conjunctival SARS-CoV-2, Fireworks-Related Eye Injuries, and More

Our editors summarize the most exciting studies from Ophthalmology, Ophthalmology Retina, American Journal of Ophthalmology, JAMA Ophthalmology, and other journals.

Comments 0
Views 139

News in Review

In 10 Days: From Skin Cells to Photoreceptors

New path to modeling eye disease.

Comments 0
Views 154

Cataract Surgery Safe in Patients With Heart Failure

Under the right conditions, LVADs need not be a contraindication for cataract surgery.

Comments 0
Views 4109

AI Used to Dx Optic Nerve Abnormalities

Deep learning neural networks to distinguish papilledema from other optic neuropathies.

Comments 0
Views 136

Real-World Study of Brolucizumab Finds Severe Retinal Vasculitis

Early outcomes of brolucizumab injections.

Comments 0
Views 3126

Academy Notebook

News, Tips, Resources

Virtual Advocacy Day highlights. Submit your benchmarking data by July 31. And more.

Comments 0
Views 48

Destination AAO

Get Ready for AAO 2020 Virtual

The world’s largest ophthalmology meeting will be fully virtual for the first time this year. To help you navigate AAO 2020 Virtual, EyeNet provides the information that you’ll need, including deadlines, event previews, sneak peeks, and more.

Comments 0
Views 2742

Practice Perfect

The New Normal: Nuances of the Hybrid Telehealth/In-Person Exam

By Joy Woodke, COE, OCS, OCSR, Academy Coding and Practice Management Executive, and Sue Vicchrilli, COT, OCS, OCSR, Academy Director of Coding and Reimbursement

For hybrid telemedicine exams, ophthalmologists need to keep several issues in mind, including informed consent, frequency limits, bundling, and MIPS.

Comments 0
Views 2358

Savvy Coder

New Prior Authorization Requirements for Blepharoplasty and Botox in HOPDs

By Emon Alavi, MS, Academy Health Policy Specialist, Jenny Edgar, CPC, CPCO, OCS, OCSR, Academy Manager, Coding and Reimbursement, and Sue Vicchrilli, COT, OCS, OCSR, Academy Director, Coding and Reimbursement

Starting July 1, 2020, there are new rules for hospital outpatient departments (HOPDs): Before clinicians perform eyelid surgery or inject Botox (botulinum toxin), the HOPD must 1) request a prior authorization and 2) receive a provisional affirmation decision.

Comments 0
Views 813

Opinion

Being Safe and Feeling Safe

Thoughts on physical—and emotional—safety.

Comments 0
Views 601

Current Perspective

COVID-19 Legacy: Science and Trust

Medicine may have had some failures during the pandemic, but science will be at the heart of victory over COVID-19, earning renewed appreciation and respect.

Comments 0
Views 376

Letters

Thoughts From Your Colleagues

Mask-related diagnostic problems: When a mask masked the diagnosis. Mask-related diagnostic artifacts. Oral-flora endophthalmitis after intravitreal injection despite universal face mask use. Slowdown by subspecialty during the pandemic. Keeping up with Fuchs dystrophy.

Comments 0
Views 1989

New Cancer Tx, New Ocular Side Effects

The EyeWiki Experiment